Cardiovascular determinants of survival in cirrhosis

Gut

Volumn 56, Issue 6, 2007, Pages 746-748

  Lee, Samuel S ^a,b   Liu, Hongqun ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; MORTALITY; NOTE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

DIASTOLE; HUMANS; LIVER CIRRHOSIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; TREATMENT OUTCOME;

EID: 34249797275     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.112169     Document Type: Note

References (24)

1. Penttila A. Sudden and unexpected natural deaths of adult males. An analysis of 799 forensic autopsies in 1976. Forensic Sci Int 1980;16:249-59.
2. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-31.
3. Suman A, Barnes DS, Zein NN, et al. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol 2004;2:719-23.
4. Deltenre P, Mathurin S, Dharancy R, et al. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int, 2005;25, 349-56.
5. Yoon CJ, Chung JW, Park JH. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding in patients with viral liver cirrhosis: predictors or early mortality. Am J Roentgenol 2005;185:885-9.
6. Russo MW, Jacques PF, Maura M, et al. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transpl 2002;8:271-7.
7. Cazzaniga M, Salerno F, Pagnozzi G. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut 2007;56:867-73.
8. Oh JK, Hatle L, Tajik AJ, et al. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006;47:500-6.
9. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451-9.
10. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002;87:9-15.
11. Liu H, Gaskari SA, Lee SS. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol 2006;12:837-42.
12. Ruiz-del-Arbol L, Urman J, Fernandez J, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38:1210-18.
13. Ruiz-del-arbol L, Monescillo A, Arocens C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005;42:439-47.
14. Lee SS. Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy? Hepatology 2003;38:1089-91.
15. Gaskari SA, Honar H, Lee SS. Therapy insight: cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol 2006;3:329- 37.
16. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000;6:S44-52.
17. Huonker M, Schumacher YO, Ochs A, et al. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44:743-8.
18. Merli M, Valeriano V, Funaro S, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002;97:142-8.
19. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839- 47.
20. Rabie R, Cazzaniga M, Salerno F, et al. Effect of cirrhotic cardiomyopathy on post-TIPS outcome of patients treated for complications of portal hypertension. Hepatology 2006;44(Suppl 1):444A.
21. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut 2001;49:268-75.
22. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997;26:1131-7.
23. Salerno F, Cazzaniga M, Pagnozzi G, et al. Humoral and cardiac effects of TIPS in cirrhotic patients with different "effective" blood volume. Hepatology 2003;38:1370-7.
24. Bernardi M, Calandra S, Colantoni A, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998;27:28-34.